2'-O-methyl-modified RNAs act as TLR7 antagonists - PubMed (original) (raw)
doi: 10.1038/sj.mt.6300240. Epub 2007 Jun 19.
Affiliations
- PMID: 17579574
- DOI: 10.1038/sj.mt.6300240
Free article
2'-O-methyl-modified RNAs act as TLR7 antagonists
Marjorie Robbins et al. Mol Ther. 2007 Sep.
Free article
Abstract
RNA molecules such as single-stranded RNA (ssRNA) and small interfering RNA (siRNA) duplexes induce Toll-like receptor (TLR)-mediated immune stimulation after intracellular delivery. We have previously shown that selective incorporation of 2'-O-methyl (2'OMe) residues into siRNA abrogates cytokine production without reduction of gene silencing activity. Here we show that 2'OMe-modified RNA acts as a potent inhibitor of RNA-mediated cytokine induction in both human and murine systems. This activity does not require the direct incorporation of 2'OMe nucleotides into the immunostimulatory RNA or that the 2'OMe nucleotide-containing RNA be annealed as a complementary strand to form a duplex. Our results indicate that 2'OMe RNA acts as a potent antagonist of immunostimulatory RNA. We further show that 2'OMe RNA is able significantly to reduce both interferon-alpha (IFN-alpha) and interleukin-6 (IL-6) induction by the small-molecule TLR7 agonist loxoribine in human peripheral blood mononuclear cells (human PBMCs), in murine Flt3L dendritic cells (Flt3L DCs), and in vivo in mice. These results indicate that 2'OMe-modified RNA may have utility as an inhibitor of TLR7 with potential applications in the treatment of inflammatory and autoimmune diseases that involve TLR7-mediated immune stimulation.
Similar articles
- Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo.
Judge AD, Bola G, Lee AC, MacLachlan I. Judge AD, et al. Mol Ther. 2006 Mar;13(3):494-505. doi: 10.1016/j.ymthe.2005.11.002. Epub 2005 Dec 15. Mol Ther. 2006. PMID: 16343994 - Sequence-dependent off-target inhibition of TLR7/8 sensing by synthetic microRNA inhibitors.
Sarvestani ST, Stunden HJ, Behlke MA, Forster SC, McCoy CE, Tate MD, Ferrand J, Lennox KA, Latz E, Williams BR, Gantier MP. Sarvestani ST, et al. Nucleic Acids Res. 2015 Jan;43(2):1177-88. doi: 10.1093/nar/gku1343. Epub 2014 Dec 24. Nucleic Acids Res. 2015. PMID: 25539920 Free PMC article. - 2'O-Ribose Methylation of Ribosomal RNAs: Natural Diversity in Living Organisms, Biological Processes, and Diseases.
Jaafar M, Paraqindes H, Gabut M, Diaz JJ, Marcel V, Durand S. Jaafar M, et al. Cells. 2021 Jul 31;10(8):1948. doi: 10.3390/cells10081948. Cells. 2021. PMID: 34440717 Free PMC article. Review. - Deciphering the code of innate immunity recognition of siRNAs.
Sioud M. Sioud M. Methods Mol Biol. 2009;487:41-59. doi: 10.1007/978-1-60327-547-7_2. Methods Mol Biol. 2009. PMID: 19301641 Review.
Cited by
- Molecular mechanisms and antisense oligonucleotide therapies of familial amyotrophic lateral sclerosis.
Al Dera H, AlQahtani B. Al Dera H, et al. Mol Ther Nucleic Acids. 2024 Jul 17;35(3):102271. doi: 10.1016/j.omtn.2024.102271. eCollection 2024 Sep 10. Mol Ther Nucleic Acids. 2024. PMID: 39176177 Free PMC article. Review. - Targeting Liver Xor by GalNAc-siRNA Is an Effective Strategy for Hyperuricemia Therapy.
Sun H, Wang X, Li Y, Shen Y, Zhang L, Xu Y, Liu J, Fan X. Sun H, et al. Pharmaceutics. 2024 Jul 14;16(7):938. doi: 10.3390/pharmaceutics16070938. Pharmaceutics. 2024. PMID: 39065635 Free PMC article. - Atom-Modified gDNA Enhances Cleavage Activity of TtAgo Enabling Ultra-Sensitive Nucleic Acid Testing.
Zhang J, Chen M, Jiang H, Sun H, Ren J, Yang X, Liu S, Wang D, Huang Z, Liu J, Ma D, Guo X, Luo G. Zhang J, et al. Adv Sci (Weinh). 2024 Jul;11(28):e2403120. doi: 10.1002/advs.202403120. Epub 2024 May 10. Adv Sci (Weinh). 2024. PMID: 38728591 Free PMC article. - Cholesterol-Modified Anti-Il6 siRNA Reduces the Severity of Acute Lung Injury in Mice.
Chernikov IV, Bachkova IK, Sen'kova AV, Meschaninova MI, Savin IA, Vlassov VV, Zenkova MA, Chernolovskaya EL. Chernikov IV, et al. Cells. 2024 Apr 30;13(9):767. doi: 10.3390/cells13090767. Cells. 2024. PMID: 38727303 Free PMC article. - Optimized allele-specific silencing of the dominant-negative COL6A1 G293R substitution causing collagen VI-related dystrophy.
Brull A, Sarathy A, Bolduc V, Chen GS, McCarty RM, Bönnemann CG. Brull A, et al. Mol Ther Nucleic Acids. 2024 Mar 22;35(2):102178. doi: 10.1016/j.omtn.2024.102178. eCollection 2024 Jun 11. Mol Ther Nucleic Acids. 2024. PMID: 38617974 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources